<DOC>
	<DOCNO>NCT00315068</DOCNO>
	<brief_summary>Catheter ablation use radiofrequency new therapeutic tool treat atrial fibrillation high success rate medical therapy ( 80 % versus le 50 % respectively ) . Because length intervention risk complication procedure , would important determine success rate intervention . The information gain study probability improve estimation chance successful intervention may enable u take necessary therapeutic measure case elevate risk recurrence . Multiple study suggest 2 marker study could provide information nature , however , utility radiofrequency catheter ablation treatment atrial fibrillation never demonstrate .</brief_summary>
	<brief_title>Usefulness Markers Predict Recurrence Atrial Fibrillation After Radiofrequency Catheter Ablation</brief_title>
	<detailed_description>Catheter ablation atrial fibrillation recent therapeutic tool treat atrial fibrillation . The success rate eliminate atrial fibrillation radiofrequency catheter ablation 80 % , one sometimes two procedure , 20-50 % drug treatment . This intervention may complicate : hematoma puncture site â€“ 1 % incidence ; thromboembolic event &lt; 1 % incidence ; cardiac perforation tamponade &lt; 1 % , pulmonary vein stenosis 2 % incidence . The aim study evaluate blood test biological product ( NT-proBNP CRP ) marker prognosis success radiofrequency catheter ablation atrial fibrillation . Previous study demonstrate prognostic value NT-proBNP CRP recurrence atrial fibrillation electrical cardioversion . However prognostic value biomarkers never demonstrate set radiofrequency catheter ablation atrial fibrillation . This observation study include 180 patient indication catheter ablation atrial fibrillation . Confounding factor increase NT-proBNP assess echocardiographic imaging .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>atrial fibrillation indication catheter ablation atrial fibrillation significant valvulopathy previous catheter ablation atrial fibrillation atrial flutter leave ventricular ejection fraction &lt; 30 % Severe heart failure ( NYHA IV ) Severe enlargement leave atrium ( &gt; 55mm )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>arrythmia</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>protein</keyword>
</DOC>